Sheriza Baksh

1000 total citations
13 papers, 231 citations indexed

About

Sheriza Baksh is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Infectious Diseases. According to data from OpenAlex, Sheriza Baksh has authored 13 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Psychiatry and Mental health and 1 paper in Infectious Diseases. Recurrent topics in Sheriza Baksh's work include Diabetes Treatment and Management (4 papers), Psychosomatic Disorders and Their Treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Sheriza Baksh is often cited by papers focused on Diabetes Treatment and Management (4 papers), Psychosomatic Disorders and Their Treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). Sheriza Baksh collaborates with scholars based in United States, Australia and Canada. Sheriza Baksh's co-authors include G. Caleb Alexander, Hsien‐Yen Chang, Sonal Singh, Omar Mansour, David Shade, Lea T. Drye, Jodi B Segal, Stephan Ehrhardt, Mara McAdams‐DeMarco and Lon S. Schneider and has published in prestigious journals such as Nature Medicine, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Sheriza Baksh

11 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheriza Baksh United States	5	120	60	55	46	35	13	231
Dhouha Haj Mouhamed Tunisia	10	50 0.4×	39 0.7×	24 0.4×	51 1.1×	34 1.0×	20	328
Jialin Wang China	11	27 0.2×	34 0.6×	30 0.5×	48 1.0×	25 0.7×	18	308
Ji-Hee Haam South Korea	9	92 0.8×	32 0.5×	19 0.3×	38 0.8×	32 0.9×	17	286
Mehmet Nuri Turan Türkiye	10	43 0.4×	28 0.5×	35 0.6×	65 1.4×	16 0.5×	27	330
Jun Sato Japan	9	32 0.3×	49 0.8×	17 0.3×	71 1.5×	39 1.1×	20	319
R Palencia Germany	7	183 1.5×	53 0.9×	31 0.6×	29 0.6×	7 0.2×	25	386
Konstantinos Koutsampasopoulos Greece	7	148 1.2×	82 1.4×	20 0.4×	60 1.3×	11 0.3×	18	324
S C Hunt United States	11	127 1.1×	67 1.1×	26 0.5×	64 1.4×	57 1.6×	13	429
Satsue Nagahama Japan	8	48 0.4×	15 0.3×	30 0.5×	32 0.7×	30 0.9×	14	214
Moutusi Raychaudhuri India	7	187 1.6×	33 0.6×	10 0.2×	45 1.0×	35 1.0×	12	370

Countries citing papers authored by Sheriza Baksh

Since Specialization

Citations

This map shows the geographic impact of Sheriza Baksh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheriza Baksh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheriza Baksh more than expected).

Fields of papers citing papers by Sheriza Baksh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheriza Baksh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheriza Baksh. The network helps show where Sheriza Baksh may publish in the future.

Co-authorship network of co-authors of Sheriza Baksh

This figure shows the co-authorship network connecting the top 25 collaborators of Sheriza Baksh. A scholar is included among the top collaborators of Sheriza Baksh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheriza Baksh. Sheriza Baksh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Rajji, Tarek K., Sheriza Baksh, David Shade, et al.. (2025). Escitalopram for agitation in Alzheimer’s dementia: a randomized controlled phase 3 trial. Nature Medicine. 31(5). 1586–1591. 2 indexed citations

Jabs, Douglas A., Elizabeth A. Sugar, Alyce Burke, et al.. (2025). Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial. Ophthalmology. 133(3). 310–325.

Rajji, Tarek K., Sheriza Baksh, David Shade, et al.. (2024). Escitalopram for Agitation in Alzheimer’s Dementia. Alzheimer s & Dementia. 20(S6). 1 indexed citations

Stefano, Leon Di, Malathi Ram, Daniel O. Scharfstein, et al.. (2023). Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis. Medicine. 102(23). e33904–e33904. 1 indexed citations

Baksh, Sheriza, Jiajun Wen, Omar Mansour, et al.. (2021). Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study. Scientific Reports. 11(1). 16637–16637. 2 indexed citations

Baksh, Sheriza, Jodi B Segal, Mara McAdams‐DeMarco, et al.. (2020). Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease. PLoS ONE. 15(10). e0240141–e0240141. 6 indexed citations

Appel, Lawrence J., Erin D. Michos, Christine Mitchell, et al.. (2020). The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults. Annals of Internal Medicine. 174(2). 145–156. 49 indexed citations

Ehrhardt, Stephan, Anton P. Porsteinsson, Cynthia A. Munro, et al.. (2019). Escitalopram for agitation in Alzheimer's disease (S‐CitAD): Methods and design of an investigator‐initiated, randomized, controlled, multicenter clinical trial. Alzheimer s & Dementia. 15(11). 1427–1436. 34 indexed citations

Baksh, Sheriza, Mara McAdams‐DeMarco, Jodi B Segal, & G. Caleb Alexander. (2018). Cardiovascular safety signals with dipeptidyl peptidase‐4 inhibitors: A disproportionality analysis among high‐risk patients. Pharmacoepidemiology and Drug Safety. 27(6). 660–667. 12 indexed citations

10.

Chang, Hsien‐Yen, Sonal Singh, Omar Mansour, Sheriza Baksh, & G. Caleb Alexander. (2018). Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. JAMA Internal Medicine. 178(9). 1190–1190. 121 indexed citations

11.

Fox, Mary A., Sheriza Baksh, Juleen Lam, & Beth Resnick. (2017). Building the Future of Environmental Public Health Tracking: Proceedings and Recommendations of an Expert Panel Workshop.. PubMed. 79(10). 14–9. 1 indexed citations

12.

Baksh, Sheriza, Walid F. Gellad, & G. Caleb Alexander. (2016). Maximizing the Post-Approval Safety of Flibanserin: A Role for Regulators, Clinicians, and Patients. Drug Safety. 39(5). 375–380. 2 indexed citations

13.

Baksh, Sheriza, et al.. (2016). Maximierung der Sicherheit von Flibanserin: Die Rolle von Aufsichtsbehörden, Klinikern und Patientinnen. Zeitschrift für Sexualforschung. 29(2). 176–186.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact